Since the cancer-causing mutants of EGF-R, Met, Flt3 and gp130 also initiate their signals from organelles,64, 69, 70, 71, 72, 73 intracellular delivery of TKIs to signaling platforms will open new fields for targeting therapy. Here, FLT3 is linked to cancer.